EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSSLDG00000007310
Gene Symbol: DHCR24
3 Cross references
208 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 11b

Ensembl ID : ENSSLDG00000023708
Gene Symbol: LOC111655443
3 Cross references
220 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4

Ensembl ID : ENSSLDG00000015045
Gene Symbol: LOC111657638
3 Cross references
226 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 4-Like

Ensembl ID : ENSSLDG00000015499
Gene Symbol: LOC111650919
3 Cross references
220 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 6-Like

Ensembl ID : ENSSLDG00000001450
Gene Symbol: LOC111663331
3 Cross references
211 Possible Orthologues:

26s Proteasome Regulatory Subunit 7 Homolog A-Like

Ensembl ID : ENSSLDG00000006639
Gene Symbol: LOC111647699
2 Cross references
155 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSSLDG00000010504
Gene Symbol: HMGCR
3 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase-Like

Ensembl ID : ENSSLDG00000013913
Gene Symbol: LOC111666845
3 Cross references
205 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSSLDG00000012521
Gene Symbol: LOC111672886
3 Cross references
208 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSSLDG00000013442
Gene Symbol: PDPK1
3 Cross references
221 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSSLDG00000012573
Gene Symbol: LOC111644885
3 Cross references
204 Possible Orthologues:

40s Ribosomal Protein S19

Ensembl ID : ENSSLDG00000002506
Gene Symbol: LOC111651149
3 Cross references
308 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).